Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.
Journal articles
- Journal Article
Schrum, DP; Eberwein, E; Cheng, S; Feng, A; Kennedy, E; Choi, T; Huggins, J; Kang, Y; Kirby, S; McKinney, M; Ramalingam, S; Stefanovic, A ...
Published in: Br J Haematol
April 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
April 2026
Volume
208
Issue
4
Start / End Page
1458 / 1461
Location
England
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schrum, D. P., Eberwein, E., Cheng, S., Feng, A., Kennedy, E., Choi, T., … Lin, C. (2026). Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel. Br J Haematol, 208(4), 1458–1461. https://doi.org/10.1111/bjh.70343
Schrum, Daniel P., Erin Eberwein, Sikai Cheng, Amber Feng, Erin Kennedy, Taewoong Choi, Jonathan Huggins, et al. “Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.” Br J Haematol 208, no. 4 (April 2026): 1458–61. https://doi.org/10.1111/bjh.70343.
Schrum DP, Eberwein E, Cheng S, Feng A, Kennedy E, Choi T, et al. Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel. Br J Haematol. 2026 Apr;208(4):1458–61.
Schrum, Daniel P., et al. “Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.” Br J Haematol, vol. 208, no. 4, Apr. 2026, pp. 1458–61. Pubmed, doi:10.1111/bjh.70343.
Schrum DP, Eberwein E, Cheng S, Feng A, Kennedy E, Choi T, Huggins J, Kang Y, Kirby S, McKinney M, Ramalingam S, Stefanovic A, Wang J, Horwitz ME, Lin C. Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel. Br J Haematol. 2026 Apr;208(4):1458–1461.
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
April 2026
Volume
208
Issue
4
Start / End Page
1458 / 1461
Location
England
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology